OmniActive Health Technologies has received the Frost & Sullivan 2011 Global Product Differentiation Excellence Award for its Lutemax 2020 lutien and zeaxanthin eye health ingredient. Frost & Sullivan measured key benchmarks including unique product development, quality assurance, market acceptance, potential growth opportunities and brand perceptions. Lutemax 2020 combines a unique balance of lutein with two additional carotenoids—RR-zeaxanthin and RS-(meso)-zeaxanthin—in a bioavailable ratio. For further information: www.omniactives.com